Norris Perne & French LLP MI Has $15.51 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Norris Perne & French LLP MI increased its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 91.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 956,625 shares of the company's stock after purchasing an additional 455,963 shares during the period. Norris Perne & French LLP MI owned about 0.14% of Avantor worth $15,507,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Avantor by 10.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company's stock worth $132,000 after buying an additional 592 shares in the last quarter. American Trust lifted its holdings in shares of Avantor by 4.5% during the 4th quarter. American Trust now owns 15,198 shares of the company's stock worth $320,000 after acquiring an additional 658 shares during the period. Oregon Public Employees Retirement Fund boosted its position in shares of Avantor by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 138,465 shares of the company's stock valued at $2,917,000 after acquiring an additional 765 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after acquiring an additional 830 shares in the last quarter. Finally, Nissay Asset Management Corp Japan ADV increased its stake in Avantor by 1.0% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 82,523 shares of the company's stock valued at $1,767,000 after acquiring an additional 857 shares during the period. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Joseph R. Massaro bought 8,100 shares of the company's stock in a transaction dated Tuesday, April 29th. The stock was bought at an average price of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the transaction, the director now directly owns 35,038 shares in the company, valued at $430,967.40. The trade was a 30.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Gregory L. Summe purchased 25,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the acquisition, the director now owns 50,000 shares of the company's stock, valued at $600,000. The trade was a 100.00% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 83,100 shares of company stock valued at $1,027,630 over the last three months. 1.20% of the stock is owned by insiders.

Avantor Trading Up 1.2%

Shares of AVTR opened at $13.31 on Thursday. Avantor, Inc. has a 52-week low of $11.82 and a 52-week high of $28.00. The company has a market cap of $9.07 billion, a price-to-earnings ratio of 12.80, a PEG ratio of 1.32 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.75 and a current ratio of 1.12. The stock has a fifty day moving average price of $13.46 and a two-hundred day moving average price of $17.29.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting analysts' consensus estimates of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The company's revenue was down 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 EPS. Analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have commented on AVTR shares. The Goldman Sachs Group cut shares of Avantor from a "buy" rating to a "neutral" rating and cut their price target for the stock from $23.00 to $14.00 in a research note on Tuesday, April 29th. Stifel Nicolaus cut Avantor from a "buy" rating to a "hold" rating and dropped their target price for the stock from $26.00 to $14.00 in a report on Monday, April 28th. Morgan Stanley downgraded Avantor from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, April 29th. TD Cowen cut Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target on the stock. in a research report on Monday, April 28th. Finally, Cowen lowered Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $18.88.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.